Ulcerative Colitis: The Complete Guide to Medical Management

ISBN-13: 9781556429453 / Angielski / Twarda / 2011 / 504 str.

G. Lichtenstein; Gary R. Lichtenstein

Opis

Ulcerative Colitis: The Complete Guide to Medical Management serves as the definitive source for medical management of ulcerative colitis (UC).

Dr. Gary R. Lichtenstein, along with Dr. Ellen J. Scherl, have collaborated with over 60 experts from around the world to provide gastroenterologists and those in training with the necessary information to successfully manage the patient with ulcerative colitis.

Sections Include:
- General
o The role of the FDA in drug development; pediatric considerations; disease modifiers; and more
- Medications
o Antibiotic use in treatment of UC; oral novel biological therapies for UC; calcineurin inhibitors use in UC; novel biologic and non-biologic therapy for UC; and more
- Specific Clinical Presentations
o Medical management of toxic megacolon; management of extraintestinal manifestations; medical therapy of left-sided UC; use of prebiotics and probiotics; maintenance of remission; and more

Features:
- Color images, graphs, and tables
- Extensive index that includes cross-referencing to Crohn's Disease: The Complete Guide to Medical Management
- Comprehensive references at the end of each chapter

Organized into an easy-to-reference format, Ulcerative Colitis: The Complete Guide to Medical Management threads theory into practice and provides gastroenterology professionals with the most comprehensive information available.

The other side of inflammatory bowel disease is covered in Drs. Gary R. Lichtenstein and Ellen J. Scherl's Crohn's Disease: The Complete Guide to Medical Management. All gastroenterologists will find both books to be essential for future practice in the treatment and care of their patients with either Crohn's disease or ulcerative colitis, as well as in the overall management of those with inflammatory bowel disease.

Spis treści

 

Dedication

Acknowledgments

About the Editor and Associate Editor

Contributing Authors

Introduction

 

Prologue        Historical Perspective of Ulcerative Colitis

                        Ming V. Lin, MD; Wojciech Blonski, MD, PhD; David Kotlyar, MD; and Gary R. Lichtenstein, MD,
                        FACP, FACG, AGAF

 

Section I   General

Chapter 1       The Natural History of Inflammatory Bowel Disease

                        Pietro G. Andres, MD and Lawrence S. Friedman, MD

Chapter 2       Clinical Research in Inflammatory Bowel Disease: Placebo Response in Clinical Trials

                        Chinyu Su, MD and James D. Lewis, MD, MSCE

Chapter 3       The Role of the FDA in Drug Development in Inflammatory Bowel Disease

                        Alan C. Moss, MD, FACG and Adam S. Cheifetz, MD

Chapter 4       Utility of Animal Models for the Study and Treatment of Inflammatory Bowel Disease

                        Ashish Chawla, MD and Kenneth Simpson, BVM&S, PhD

Chapter 5       Pediatric Considerations in Medical Therapy in Patients With Inflammatory Bowel Disease

                        Louis R. Ghanem, MD, PhD and Robert N. Baldassano, MD

Chapter 6       The Limitations of Applying Evidence-Based Medicine to Inflammatory Bowel Disease:

                        What We Do Not Learn From Clinical Trials

                        Joshua R. Korzenik, MD and Corey A. Siegel, MD

Chapter 7       Disease Modifiers in Inflammatory Bowel Disease

                        Jaime A. Oviedo, MD and Francis A. Farraye, MD, MSc, FACP, FACG

Chapter 8       Fertility and Pregnancy in Inflammatory Bowel Disease

                        Jeffry A. Katz, MD and Vinita Elizabeth Jacob, MD

Chapter 9       Diversion Colitis

                        Eugeni Domènech, MD, PhD and Miguel A. Gassull, MD, PhD

 

Chapter 10     Medication Adherence in Inflammatory Bowel Disease

                        Sunanda V. Kane, MD, MSPH, FACG, FACP, AGAF

Section II Medications

Chapter 11     General Principles of Medical Therapy of Ulcerative Colitis

                        Sonia Friedman, MD, FACP

Chapter 12     Assessment of Disease Activity in Ulcerative Colitis

                        Anthony L. Rosa, MD and Thomas A. Judge, MD

 

Chapter 13     Current and Future Oral Mesalamine Derivative Use in Ulcerative Colitis

                        Lloyd Sutherland, MDCM, MSc, FRCP(C), FACP

Chapter 14     Current and Future Topical Mesalamine Derivatives in Ulcerative Colitis

                        Jeffrey W. Nathanson, MD and Russell D. Cohen, MD

Chapter 15     Antibiotics in Ulcerative Colitis

                        Kim L. Isaacs, MD, PhD

Chapter 16     Oral and Parenteral Corticosteroids in Ulcerative Colitis

                        Leonard Baidoo, MD and Gary R. Lichtenstein, MD, FACP, FACG, AGAF

Chapter 17     Topical Corticosteroid Use in Ulcerative Colitis

                        Seymour Katz, MD, FACP, MACG

Chapter 18     6-Mercaptopurine and Azathioprine Use in Ulcerative Colitis

                        Marla C. Dubinsky, MD

Chapter 19     Azathioprine Metabolism in Inflammatory Bowel Disease:

                        A Physician’s Guide to Metabolite Testing

                        Carmen Cuffari, MD

Chapter 20     Methotrexate in the Treatment of Ulcerative Colitis

                        Ellen J. Scherl, MD, FACP, AGAF; Vinita Elizabeth Jacob, MD; Brian P. Bosworth, MD;
                        Ryan Urquhart Warren, MD; and Harrison Lakehomer, BA

Chapter 21     Calcineurin Inhibitors (Cyclosporine, Tacrolimus, Sirolimus) and Mycophenolate Motefil Use in
                        Ulcerative Colitis

                        Hans Herfarth, MD, PhD and Jürgen Schölmerich, MD, PhD

Chapter 22     Infliximab Use in Ulcerative Colitis

                        Wojciech Blonski, MD, PhD; Antoni Stadnicki, MD, PhD; Gary R. Lichtenstein, MD, FACP, FACG, AGAF;                                 and Anne Burke, MD

Chapter 23     Other Tumor Necrosis Factor-Alpha Antagonists in Ulcerative Colitis

                        Joshua R. Korzenik, MD

Chapter 24     Novel Biological Agents for the Treatment of Ulcerative Colitis

                        Gert Van Assche, MD, PhD, FRCP and Paul Rutgeerts, MD, PhD, FRCP

Chapter 25     Novel Nonbiologic Therapy for Ulcerative Colitis

                        William J. Sandborn, MD

Section III........................................................................................... Specific ClinicalPresentations

Chapter 26     Medical Management of Severe Ulcerative Colitis

                        Niraj Jani, MD and Miguel Regueiro, MD

Chapter 27     Medical Management of Toxic Megacolon in the Patient with Ulcerative Colitis

                        Robynne Chutkan, MD and Nabil Toubia, MD

Chapter 28     Medical Management of Ulcerative Proctitis

                        Philip B. Miner Jr, MD

Chapter 29     Medical Therapy of Left-Sided Ulcerative Colitis

                        Douglas B. Haghighi, DMD, MD and Bret A. Lashner, MD, MPH

Chapter 30     Management of Refractory Ulcerative Colitis

                        Edward V. Loftus Jr, MD; Ellen J. Scherl, MD, FACP, AGAF; and Melissa H. Rosen, MD

Chapter 31     Pseudointractability of Inflammatory Bowel Disease

                        Mansour A. Parsi, MD and Jean-Paul Achkar, MD

Chapter 32     Medical Management of Extraintestinal Manifestations of Ulcerative Colitis

                        Lloyd Mayer, MD and Robert Pittman, MD

Chapter 33     Nicotine and Inflammatory Bowel Disease

                        Truc T. Trinh, MD; Richard S. Bloomfeld, MD, MS; and Stephen J. Bickston, MD, AGAF

Chapter 34     Management of Steroid-Refractory and Steroid-Dependent Severe Ulcerative Colitis

                        Jesse A. Green, MD, FACG and Richard P. MacDermott, MD, FACG

Chapter 35     Prebiotics and Probiotics in Ulcerative Colitis

                        Robert M. Penner, BSc, MD, FRCP(C), MSc; Karen L. Madsen, PhD; Massimo Campieri, MD;   
                        and Richard N. Fedorak, MD, FRCP(C)

Chapter 36     Management of Acute and Chronic Pouchitis

                        James M. Becker, MD, FACS and Arthur F. Stucchi, PhD

Chapter 37     Dietary Manipulations: Oral and Enteral Nutritional Therapy for Ulcerative Colitis

                        Traci M. Temmen, MD and John L. Rombeau, MD

Chapter 38     Parenteral Nutrition Use in Ulcerative Colitis

                        Alan L. Buchman, MD, MSPH

Chapter 39     Maintenance of Remission in Ulcerative Colitis

                        Kenneth W. Schroeder, MD, PhD and William J. Tremaine, MD

Financial Disclosures

 

Index